Hormone receptor and Her2/neu status pre and post neoadjuvant chemotherapy in breast cancer: Should immunohistochemical studies be repeated?

被引：0
|
作者：
Allison, KA [1 ]
Swanson, PE [1 ]
Lawton, TJ [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
80
引用
收藏
页码：20A / 20A
页数：1
相关论文
共 50 条
  • [41] Steroid hormone status and HER2/neu expression in pregnancy-associated breast cancer
    Litwiniuk, M.
    Breborowicz, E.
    Breborowicz, D.
    Filas, V.
    Breborowicz, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Breast Carcinoma, Receptor Status, and Her2 neu Overexpression Revisited
    Puvitha, R. D.
    Shifa, S.
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 3 (10) : 52 - 58
  • [43] Effect of Neoadjuvant Chemotherapy on Hormone and Her2neu Receptor Expression in Breast Cancer Patients—a Prospective Cohort Study
    Janitta Kundaikar
    Shaji Thomas
    Kiran Aggarwal
    O. P. Pathania
    Manoj Andley
    Indian Journal of Surgery, 2021, 83 : 504 - 510
  • [44] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Yihong Wang
    Kamaljeet Singh
    Don Dizon
    Teresa Graves
    Ali Amin
    Evgeny Yakirevich
    Breast Cancer Research and Treatment, 2021, 186 : 667 - 676
  • [45] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Wang, Yihong
    Singh, Kamaljeet
    Dizon, Don
    Graves, Teresa
    Amin, Ali
    Yakirevich, Evgeny
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 667 - 676
  • [46] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [47] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer reply
    Baselga, Jose
    de Azambuja, Evandro
    Bradbury, Ian
    Gelber, Richard
    LANCET, 2012, 379 (9833): : 2238 - 2238
  • [48] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [49] Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer
    Kaklamani, Virginia G.
    Cianfrocca, Mary
    Ciccone, Jennifer
    Kindy, Kelly
    Rademaker, Alfred
    Wiley, Elizabeth L.
    Gradishar, William
    O'Regan, Ruth M.
    BIOMARKERS, 2010, 15 (02) : 191 - 193
  • [50] Assessment of Estrogen Receptor, Progesterone Receptor and HER2 in Breast Cancers in Nigeria: A Comparison between Pre and Post Neoadjuvant Chemotherapy Results
    Betiku, Omolade
    Omoyiola, Oluwatosin
    Odujoko, Oluwole
    Ntiamoah, Peter
    Farahani, Sahar
    Alatise, Olusegun
    Kingham, Peter
    Wuraola, Funmilola
    Olasehinde, Olalekan
    Edelweiss, Marcia
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1697 - S1698
12345